To summarise, while there is strong evidence that switching from NPH insulin to Gla-300 in patients with T2DM decreases hypoglycaemia risk without causing weight gain, data from randomised controlled trials are inconsistent regarding improvement in HbA1c. Here, INS is linked to type 2 diabetes mellitus.